Determination of formoterol by capillary electrophoresis and its application to inhaler capsules

Arch Pharm (Weinheim). 2003 Jul;336(4-5):226-9. doi: 10.1002/ardp.200300733.

Abstract

A capillary electrophoretic (CE) method for the determination of formoterol (FOR) in a pharmaceutical preparation is described. Analysis was made in a background electrolyte consisting of 20 % acetonitrile and 50 mM phosphoric acid at pH 2.5, using fused silica capillary (86 cm x 75 microm ID), 27 kV potential, and detecting at 200 nm. Under these electrophoretic conditions 3, 4-dihydroxybenzylamine used as an internal standard (IS) and FOR showed symmetrical peaks at 6.1 and 8.3 min., respectively. The inter-day and intra-day precision was examined in the concentration range of 2.98 x 10(-6) M to 8.94 x 10(-6) M. Good correlation and accuracy were obtained. Limit of detection, (LOD) and limit of quantitation (LOQ) values were 3.71 x 10(-7) M and 1.11 x 10(-6) M, respectively. The method was applied for the analysis of FOR in pharmaceutical inhaler capsules. The proposed method is reliable, precise, accurate, fast, and cost effective.

Publication types

  • Validation Study

MeSH terms

  • Bronchodilator Agents / isolation & purification*
  • Capsules
  • Electrolytes / chemistry
  • Electrophoresis, Capillary / methods
  • Ethanolamines / isolation & purification*
  • Formoterol Fumarate
  • Nebulizers and Vaporizers* / standards
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Bronchodilator Agents
  • Capsules
  • Electrolytes
  • Ethanolamines
  • Formoterol Fumarate